Abbott Claims DexCom CGM Suits Renege On Tech-Sharing Agreement
Executive Summary
Abbott says DexCom’s patent suits involve technology that was already the subject of a settlement, and raise venue questions.
You may also be interested in...
Dexcom, Abbott File Dueling Lawsuits On Diabetes Management Technology
The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.
Industry And Investors Ponder Legacy Of Theranos Scandal
What lessons can be learned from the conviction of Theranos founder Elizabeth Holmes, found guilty on four counts of investor fraud in a US court on 4 January?
Attorneys Mull Takeaways From Conviction Of Theranos Founder Holmes
Elizabeth Holmes has been convicted on four counts of investor fraud. Two attorneys who followed the case spoke to Medtech Insight about what happened – and what it could mean for industry as a whole.